Functional and Predictive Assays for Biotherapeutics Development

‘Our predictive assays help you assess efficacy and toxicity of your compounds’

Efficacy                                                            Toxicity

Primary cell binding                                          Thrombocytopenia

Primary cell activation                                       Neutropenia

Targeted killing                                                 Cytokine release syndrome

Cell signaling                                                    Cytokine storm


Please Download our Brochure to find out more about our services for biotherapeutics development

For Ranking Myelotoxic Potential of New Tyrosine Kinase Inhibitors

The HemoRANK(TM) – TKI Assay Service Package Includes:

  • Testing of your novel TKI compound(s) in in vitro CFC assays in parallel with a panel of 6 standard TKIs with known levels of clinical myelotoxicity
  • Ranking of in vitro myelotoxicity of test TKI(s) compared to standards
  • Prediction of clinical myelotoxicity potential of test TKI(s)
  • Full written report with data interpretation and statistical analysis
  • Full confidentiality
  • Standardized pricing

Please Download our Brochure to learn more about service package

Using our predictive toxicology and immunology assays, let us help you with your program challenges:

  • Thrombocytopenia & Platelet Development
  • Antibody Testing
  • Severe Anemia & Red Blood Cell Development
  • Neutropenia & Myeloid/Neutrophil Development
  • Lymphopenia Development
  • Target Validation
  • Cytokine Storm Concerns
  • Immuno-Oncology and Immuno-Phenotyping

Please Download our Brochure to find out more about our cellPrism® drug development assays.